IDE196 (Darovasertib) in Combination with Crizotinib Versus Investigators Choice of Treatment as First-line Therapy in HLA-A2 Negative Metastatic Uveal Melanoma (DAR-UM-2)

Project: Research

Project Details

StatusActive
Effective start/end date17/01/2416/01/26

Keywords

  • clinical trial
  • Darovasertib
  • melanoma